Quantcast

Latest schizophrenia Stories

2014-04-12 23:00:44

Arkansas Attorney General Has Asked State Supreme Court to Reconsider Its Decision to Overturn $1.2 Billion Risperdal Lawsuit Verdict Columbus, OH (PRWEB) April 12, 2014 The Risperdal lawsuit lawyers at Wright & Schulte LLC, note that the Arkansas Attorney General has filed a petition with the state’s Supreme Court asking it to reconsider a recent decision which overturned a $1.2 billion Risperdal lawsuit verdict awarded to the state in 2012 over the marketing of the antipsychotic...

2014-04-11 15:08:25

Schizophrenia is a severe disease for which there is still no effective medical treatment. In an attempt to understand exactly what happens in the brain of schizophrenic people, researchers from the University of Southern Denmark have analysed proteins in the brains of rats that have been given hallucinogenic drugs. This may pave the way for new and better medicines. Seven per cent of the adult population suffer from schizophrenia, and although scientists have tried for centuries to...

2014-04-10 23:01:50

The Firm is representing men and boys in Risperdal lawsuits who allegedly developed gynecomastia, or male breast growth, due to Risperdal. New York, New York (PRWEB) April 10, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study which reveals the off-label use of atypical antipsychotic drugs like Risperdal is rising among children in foster care. The research, which was published...

2014-04-09 08:29:20

Tetra Discovery Partners Focused on PDE4D Inhibitors as Novel Approach to Treating Cognitive Impairment in Schizophrenia, Alzheimer's Disease, and Huntington's Disease GRAND RAPIDS, Mich., April 9, 2014 /PRNewswire/ -- Tetra Discovery Partners LLC, a drug discovery company developing a portfolio of innovative drugs for neurological and inflammatory diseases, announced today that the company has entered into a drug development collaboration with the Broad Institute's Stanley Center...

2014-04-08 10:48:49

Genetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD), report scientists from the University of Chicago in the Proceedings of the National Academy of Sciences on April 7. The results support a long-standing hypothesis that dopamine, the neurotransmitter connected with the euphoric effects of amphetamine, is related to...

2014-04-03 16:23:49

MONTREAL, April 3, 2014 /CNW Telbec/ - Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus. Published in Biological Psychiatry, this discovery opens the door to a better understanding of psychiatric diseases, such as schizophrenia. Dopamine is a neurotransmitter that plays...

2014-04-03 10:07:15

People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation. The study from the Montreal Neurological Institute and Hospital – The Neuro - at McGill University and McGill University Health Centre, reveals that certain errors in visual perception in people with schizophrenia are consistent with interference or ‘noise’ in a brain signal known as a...

2014-04-01 13:11:34

Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness. The drug is one of a class of compounds known as PAK inhibitors, which have been shown in animal experiments to confer some protection from brain damage due to Fragile X syndrome, an inherited disease in humans marked by mental...

2014-04-01 08:28:09

-- Conference Focuses on New Drug Development and Cutting Edge Research in Schizophrenia -- SEATTLE, April 1, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the company was invited by the organizers of the 2014 Biennial Conference of the Schizophrenia International Research Society (SIRS) to make an oral presentation on OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor in development for the treatment of schizophrenia and Huntington's disease....

2014-03-31 12:28:30

Surveyed Psychiatrists and Payers Identify Improved Efficacy on Patient Function as a Pressing Unmet Need, According to Findings from Decision Resources Group BURLINGTON, Mass., March 31, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists would prescribe EnVivo Pharmaceuticals/Bayer HealthCare/Mitsubishi Tanabe Pharma's encenicline to 25 percent of their patients with cognitive impairment associated with schizophrenia (CIAS). Assuming its promising--albeit...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related